Skip to main content

BRS5-FM2-PM5 — SCFA Production & Signalling​

Stage 2B draft — not approved. Independent Stage 2A/2B review. Canonical science, mappings and review status are unchanged.

1. Mission & Overview​

Mission​

Maintain short-chain fatty acid production and signalling that supports gut barrier and brain communication.

Intervention Dominance: Diet-Supported — Dietary Requirements

Overview​

Gut microbes ferment carbohydrates into short-chain fatty acids (SCFAs), including acetate, propionate and butyrate. These products supply local cells and activate signalling pathways. The amount and mixture produced depend on the substrate and the microbial community. Human fermentation studies support particular inputs; cell experiments explain possible downstream actions without establishing cognitive benefit. [5]

  • Benefits: SCFA provision contributes to intestinal energy supply and signalling. Protective endothelial and mitochondrial responses are experimental findings, not proven benefits from increasing a food or supplement.
  • Implementation Notes: Defined resistant starch and oligosaccharide preparations can change fermentation. Responses vary; a faecal SCFA concentration is the balance of production, use, absorption and transit, not a direct production-flux measure.
  • Biological Relevance: SCFA production and product signalling belong here. Community processing selection belongs to PM4; epithelial junction regulation belongs to PM1. Circulating or faecal measures do not establish brain exposure.

2. Primary Biological Effects​

  • Defined resistant starch and oligosaccharide exposures support microbial SCFA provision, with variable product responses. [5]
  • Propionate and butyrate affect experimental barrier and mitochondrial endpoints. [2]

3. Intervention Levers​

4. Mechanistic Basis​

Summary​

Defined resistant starch and oligosaccharide exposures support microbial SCFA provision, with variable product responses. [5]

Biological process​

Substrate provision is supported, but product concentrations are not interchangeable with synthesis flux or tissue exposure. [5]

Mechanism Boundary​

SCFA production and product signalling belong here. Community processing selection belongs to PM4; epithelial junction regulation belongs to PM1. Circulating or faecal measures do not establish brain exposure.

Integration​

This PM contributes its specific process to its parent FM. Shared inputs do not merge distinct jobs or prove an integrated clinical outcome.

4.1 Scientific Findings​

Summary​

Human substrate interventions show variable SCFA responses. Cell experiments support specific propionate and butyrate actions. Cross-sectional ADHD microbiota/SCFA findings do not establish that these pathways cause symptoms or that supplementation improves them. [5] [6] [7] [2] [3]

5. BRS Pathways and Connections​

5.1 BRS Pathways​

No newly adjudicated pathway is added by this preview.

5.2 Cross-BRS Mechanism Relationships​

Existing connected mechanisms remain candidates in the review history; no new downstream admission is inferred.

5.3 Local BRS Mechanism Relationships​

7. Phenome Connections​

No new phenome rating or outcome admission is made in this unapproved draft. Inherited candidate relationships are preserved in the assessment record; microbial, cellular and animal findings do not automatically establish a human cognitive effect.

8. References​